{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T21:19:19Z","timestamp":1781212759204,"version":"3.54.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2023,1,3]],"date-time":"2023-01-03T00:00:00Z","timestamp":1672704000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,1,3]],"date-time":"2023-01-03T00:00:00Z","timestamp":1672704000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Ophthalmol"],"DOI":"10.1007\/s10792-022-02626-6","type":"journal-article","created":{"date-parts":[[2023,1,3]],"date-time":"2023-01-03T10:03:42Z","timestamp":1672740222000},"page":"2301-2306","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Ocular findings and their correlation with disease severity in Fabry disease in South-East Anatolia"],"prefix":"10.1007","volume":"43","author":[{"given":"Alper","family":"Mete","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4849-3698","authenticated-orcid":false,"given":"Levent","family":"Dogan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gazi Bekir","family":"Ozcakmakci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeynel Abidin","family":"Sayiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kivanc","family":"Gungor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,1,3]]},"reference":[{"issue":"1","key":"2626_CR1","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/1750-1172-5-30","volume":"5","author":"DP Germain","year":"2010","unstructured":"Germain DP (2010) Fabry disease. Orphanet J Rare Dis 5(1):30","journal-title":"Orphanet J Rare Dis"},{"key":"2626_CR2","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/B978-0-12-410529-4.00038-3","volume-title":"Rosenberg's molecular and genetic basis of neurological and psychiatric disease","author":"RJ Desnick","year":"2015","unstructured":"Desnick RJ (2015) Chapter 38\u2014Fabry Disease: \u03b1-Galactosidase A deficiency. In: Rosenberg RN, Pascual JM (eds) Rosenberg\u2019s molecular and genetic basis of neurological and psychiatric disease, 5th edn. Academic Press, Boston, pp 419\u2013430","edition":"5"},{"issue":"1","key":"2626_CR3","first-page":"393","volume":"16","author":"RJ Desnick","year":"1980","unstructured":"Desnick RJ et al (1980) Enzyme therapy XVII: metabolic and immunologic evaluation of alpha-galactosidase a replacement in Fabry disease. Birth Defects Orig Artic Ser 16(1):393\u2013413","journal-title":"Birth Defects Orig Artic Ser"},{"issue":"1","key":"2626_CR4","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.jns.2014.06.029","volume":"344","author":"R El-Abassi","year":"2014","unstructured":"El-Abassi R, Singhal D, England JD (2014) Fabry\u2019s disease. J Neurol Sci 344(1):5\u201319","journal-title":"J Neurol Sci"},{"key":"2626_CR5","doi-asserted-by":"publisher","first-page":"640719","DOI":"10.3389\/fneur.2021.640719","volume":"12","author":"D Bacherini","year":"2021","unstructured":"Bacherini D et al (2021) Optical coherence tomography angiography for the evaluation of retinal vasculature in fabry disease: our experience and review of current knowledge. Front Neurol 12:640719","journal-title":"Front Neurol"},{"issue":"7","key":"2626_CR6","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1038\/sj.ki.5000208","volume":"69","author":"F Breunig","year":"2006","unstructured":"Breunig F et al (2006) Clinical benefit of enzyme replacement therapy in Fabry disease. Kidney Int 69(7):1216\u20131221","journal-title":"Kidney Int"},{"issue":"21","key":"2626_CR7","doi-asserted-by":"publisher","first-page":"2743","DOI":"10.1001\/jama.285.21.2743","volume":"285","author":"R Schiffmann","year":"2001","unstructured":"Schiffmann R et al (2001) Enzyme replacement therapy in Fabry diseasea randomized controlled trial. JAMA 285(21):2743\u20132749","journal-title":"JAMA"},{"issue":"5","key":"2626_CR8","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1093\/ndt\/gfm848","volume":"23","author":"A Ortiz","year":"2008","unstructured":"Ortiz A et al (2008) Nephropathy in males and females with Fabry disease: cross-sectional description of patients before treatment with enzyme replacement therapy. Nephrol Dial Transpl 23(5):1600\u20131607","journal-title":"Nephrol Dial Transpl"},{"issue":"7","key":"2626_CR9","doi-asserted-by":"publisher","first-page":"2102","DOI":"10.1093\/ndt\/gfp031","volume":"24","author":"R Schiffmann","year":"2009","unstructured":"Schiffmann R et al (2009) Fabry disease: progression of nephropathy, and prevalence of cardiac and cerebrovascular events before enzyme replacement therapy. Nephrol Dial Transpl 24(7):2102\u20132111","journal-title":"Nephrol Dial Transpl"},{"issue":"10","key":"2626_CR10","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1093\/eurheartj\/ehm153","volume":"28","author":"A Linhart","year":"2007","unstructured":"Linhart A et al (2007) Cardiac manifestations of Anderson-Fabry disease: results from the international Fabry outcome survey. Eur Heart J 28(10):1228\u20131235","journal-title":"Eur Heart J"},{"issue":"3","key":"2626_CR11","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1161\/STROKEAHA.108.526293","volume":"40","author":"K Sims","year":"2009","unstructured":"Sims K et al (2009) Stroke in Fabry disease frequently occurs before diagnosis and in the absence of other clinical events. Stroke 40(3):788\u2013794","journal-title":"Stroke"},{"issue":"1","key":"2626_CR12","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1212\/01.wnl.0000338566.54190.8a","volume":"72","author":"A Fellgiebel","year":"2009","unstructured":"Fellgiebel A et al (2009) Diagnostic utility of different MRI and MR angiography measures in Fabry disease. Neurology 72(1):63","journal-title":"Neurology"},{"issue":"5","key":"2626_CR13","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1203\/PDR.0b013e318183f132","volume":"64","author":"RJ Hopkin","year":"2008","unstructured":"Hopkin RJ et al (2008) Characterization of Fabry disease in 352 pediatric patients in the Fabry registry. Pediatr Res 64(5):550\u2013555","journal-title":"Pediatr Res"},{"issue":"1","key":"2626_CR14","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1080\/08035250500275022","volume":"95","author":"U Ramaswami","year":"2006","unstructured":"Ramaswami U et al (2006) Clinical manifestations of Fabry disease in children: Data from the Fabry Outcome Survey. Acta Paediatr 95(1):86\u201392","journal-title":"Acta Paediatr"},{"issue":"2","key":"2626_CR15","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1136\/bjo.2006.100602","volume":"91","author":"A Sodi","year":"2007","unstructured":"Sodi A et al (2007) Ocular manifestations of Fabry\u2019s disease: data from the Fabry Outcome Survey. Br J Ophthalmol 91(2):210","journal-title":"Br J Ophthalmol"},{"issue":"3","key":"2626_CR16","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.ymgme.2009.10.178","volume":"99","author":"EH Giannini","year":"2010","unstructured":"Giannini EH et al (2010) A validated disease severity scoring system for Fabry disease. Mol Genet Metab 99(3):283\u2013290","journal-title":"Mol Genet Metab"},{"issue":"4","key":"2626_CR17","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1111\/j.1399-0004.2004.00219.x","volume":"65","author":"C Whybra","year":"2004","unstructured":"Whybra C et al (2004) The mainz severity score index: a new instrument for quantifying the Anderson-Fabry disease phenotype, and the response of patients to enzyme replacement therapy. Clin Genet 65(4):299\u2013307","journal-title":"Clin Genet"},{"issue":"6","key":"2626_CR18","doi-asserted-by":"publisher","first-page":"e27","DOI":"10.1016\/j.ophtha.2008.02.009","volume":"115","author":"CG Owen","year":"2008","unstructured":"Owen CG et al (2008) Diabetes and the Tortuosity of vessels of the bulbar conjunctiva. Ophthalmology 115(6):e27\u2013e32","journal-title":"Ophthalmology"},{"issue":"1","key":"2626_CR19","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1186\/s12874-018-0598-3","volume":"18","author":"L Ramos","year":"2018","unstructured":"Ramos L et al (2018) Retinal vascular tortuosity assessment: inter-intra expert analysis and correlation with computational measurements. BMC Med Res Methodol 18(1):144","journal-title":"BMC Med Res Methodol"},{"issue":"2","key":"2626_CR20","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1111\/j.1442-9071.2005.00990.x","volume":"33","author":"TT Nguyen","year":"2005","unstructured":"Nguyen TT et al (2005) Ophthalmological manifestations of Fabry disease a survey of patients at the Royal Melbourne Fabry Disease Treatment Centre. Clin Exp Ophthalmol 33(2):164\u2013168","journal-title":"Clin Exp Ophthalmol"},{"issue":"9647","key":"2626_CR21","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1016\/S0140-6736(08)61589-5","volume":"372","author":"YA Zarate","year":"2008","unstructured":"Zarate YA, Hopkin RJ (2008) Fabry\u2019s disease. The Lancet 372(9647):1427\u20131435","journal-title":"The Lancet"},{"issue":"8","key":"2626_CR22","doi-asserted-by":"publisher","first-page":"e1098","DOI":"10.1111\/aos.14143","volume":"97","author":"S Koh","year":"2019","unstructured":"Koh S et al (2019) Quantitative evaluation of visual function in patients with cornea verticillata associated with Fabry disease. Acta Ophthalmol 97(8):e1098\u2013e1104","journal-title":"Acta Ophthalmol"},{"issue":"4","key":"2626_CR23","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1001\/archopht.1979.01020010327008","volume":"97","author":"NA Sher","year":"1979","unstructured":"Sher NA, Letson RD, Desnick RJ (1979) The ocular manifestations in Fabry\u2019s Disease. Arch Ophthalmol 97(4):671\u2013676","journal-title":"Arch Ophthalmol"},{"issue":"4","key":"2626_CR24","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1007\/BF00145811","volume":"74","author":"LP Lanigan","year":"1990","unstructured":"Lanigan LP, Clark CV, Hill DW (1990) Retinal vessel responses to systemic autonomic stimulation in fellow eyes of patients with retinal vein occlusion. Doc Ophthalmol 74(4):269\u2013276","journal-title":"Doc Ophthalmol"},{"issue":"1","key":"2626_CR25","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/eye.1990.24","volume":"4","author":"LP Lanigan","year":"1990","unstructured":"Lanigan LP et al (1990) The effect of cervical sympathectomy on retinal vessel responses to systemic autonomic stimulation. Eye 4(1):181\u2013189","journal-title":"Eye"},{"issue":"6","key":"2626_CR26","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1016\/j.clinph.2008.02.004","volume":"119","author":"SM Laaksonen","year":"2008","unstructured":"Laaksonen SM et al (2008) Neuropathic symptoms and findings in women with Fabry disease. Clin Neurophysiol 119(6):1365\u20131372","journal-title":"Clin Neurophysiol"},{"issue":"12","key":"2626_CR27","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1136\/bjo.2009.176651","volume":"94","author":"LE Allen","year":"2010","unstructured":"Allen LE et al (2010) Fabry disease in children: correlation between ocular manifestations, genotype and systemic clinical severity. Br J Ophthalmol 94(12):1602","journal-title":"Br J Ophthalmol"},{"issue":"5","key":"2626_CR28","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1001\/archopht.1978.03910050421003","volume":"96","author":"NA Sher","year":"1978","unstructured":"Sher NA et al (1978) Central retinal artery occlusion complicating Fabry\u2019s disease. Arch Ophthalmol 96(5):815\u2013817","journal-title":"Arch Ophthalmol"},{"issue":"1","key":"2626_CR29","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1097\/00006982-200102000-00024","volume":"21","author":"MA Dantas","year":"2001","unstructured":"Dantas MA et al (2001) Retinal and choroidal vascular changes in heterozygous Fabry disease. Retina 21(1):87\u201389","journal-title":"Retina"},{"issue":"5","key":"2626_CR30","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1111\/j.1755-3768.1994.tb07193.x","volume":"72","author":"MVN Andersen","year":"1994","unstructured":"Andersen MVN et al (1994) Central retinal artery occlusion in a patient with Fabry\u2019s disease documented by scanning laser ophthalmoscopy. Acta ophthalmol 72(5):635\u2013638","journal-title":"Acta ophthalmol"},{"issue":"4","key":"2626_CR31","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/j.survophthal.2008.04.005","volume":"53","author":"N Samiy","year":"2008","unstructured":"Samiy N (2008) Ocular features of Fabry Disease: diagnosis of a treatable life-threatening disorder. Surv Ophthalmol 53(4):416\u2013423","journal-title":"Surv Ophthalmol"},{"key":"2626_CR32","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/978-90-481-9033-1_17","volume-title":"Fabry disease","author":"A Sodi","year":"2010","unstructured":"Sodi A (2010) The eye in Fabry disease. In: Altarescu G, Beck M, Elstein D (eds) Fabry disease. Springer, Berlin, pp 299\u2013306"},{"issue":"1","key":"2626_CR33","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1186\/s12886-016-0374-2","volume":"16","author":"G Kalkum","year":"2016","unstructured":"Kalkum G et al (2016) Paediatric Fabry disease: prognostic significance of ocular changes for disease severity. BMC Ophthalmol 16(1):202","journal-title":"BMC Ophthalmol"},{"issue":"12","key":"2626_CR34","doi-asserted-by":"publisher","first-page":"3726","DOI":"10.3390\/ijms19123726","volume":"19","author":"G Duro","year":"2018","unstructured":"Duro G et al (2018) Mutations in the GLA Gene and LysoGb3: is It really Anderson-Fabry disease? Int J Mol Sci 19(12):3726","journal-title":"Int J Mol Sci"},{"issue":"1","key":"2626_CR35","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1161\/CIRCGENETICS.113.000249","volume":"7","author":"M Niemann","year":"2014","unstructured":"Niemann M et al (2014) Gene mutations versus clinically relevant phenotypes: lyso-Gb3 defines Fabry disease. Circ Cardiovasc Genet 7(1):8\u201316","journal-title":"Circ Cardiovasc Genet"},{"issue":"4","key":"2626_CR36","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1136\/jmedgenet-2014-102872","volume":"52","author":"BE Smid","year":"2015","unstructured":"Smid BE et al (2015) Plasma globotriaosylsphingosine in relation to phenotypes of Fabry disease. J Med Genet 52(4):262","journal-title":"J Med Genet"},{"key":"2626_CR37","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.cca.2019.10.031","volume":"501","author":"GV Baydakova","year":"2020","unstructured":"Baydakova GV et al (2020) \u03b1-Galactosidase A\/lysoGb3 ratio as a potential marker for Fabry disease in females. Clin Chim Acta 501:27\u201332","journal-title":"Clin Chim Acta"}],"container-title":["International Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-022-02626-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10792-022-02626-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-022-02626-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,30]],"date-time":"2023-06-30T15:07:11Z","timestamp":1688137631000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10792-022-02626-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,3]]},"references-count":37,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2023,7]]}},"alternative-id":["2626"],"URL":"https:\/\/doi.org\/10.1007\/s10792-022-02626-6","relation":{},"ISSN":["1573-2630"],"issn-type":[{"value":"1573-2630","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,3]]},"assertion":[{"value":"30 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 December 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}